2 results about "Individualized treatment" patented technology

The invention belongs to the field of biological medicine, and relates to application of TROAP in preparation of renal cell carcinoma prognosis products and therapeutic drugs. Experiments find and prove that the TROAP gene can promote proliferation, migration and invasion of renal carcinoma cells and inhibit apoptosis at the same time, and is a very important marker for renal carcinoma progression. On the basis, the TROAP gene is used as a screened molecular marker, the prognosis condition of a renal cell carcinoma patient is judged by detecting the expression level of the TROAP, clinical treatment is guided through a prognosis model, and the application has important practical application value for evaluating the prognosis of the patient and guiding the individualized treatment of the patient. Meanwhile, the ROAP gene serves as a targeted drug development action target, a new inhibitor and a new drug development target are provided for the renal clear cell carcinoma, especially metastatic clear cell carcinoma, and the early warning capacity and the subsequent treatment effect on the patients of the type are improved.